Marion Kiechle

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

Alfons Meindl, Heide Hellebrand, Constanze Wiek et al. · Nature Genetics · 2010 · 727 citations

Breast Oncology, Somatic Variant, Cancer Pathology +9

Contralateral Breast Cancer Risk in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers

Monika Graeser, Christoph Engel, Kerstin Rhiem et al. · Journal of Clinical Oncology · 2009 · 309 citations

CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer

Holger Bronger, J. David Singer, Claudia Windmüller et al. · British Journal of Cancer · 2016 · 257 citations · Full text

Prevalence of <i>BRCA1/2</i> germline mutations in 21 401 families with breast and ovarian cancer

Karin Kast, Kerstin Rhiem, Barbara Wappenschmidt et al. · Journal of Medical Genetics · 2016 · 217 citations

Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424).

Nadia Harbeck, Ronald Kates, Maxime P. Look et al. · PubMed · 2002 · 193 citations

Breast Oncology, Breast Cancer Patients, Medicine +14